Abstract
SARS-CoV-2 infection has been associated with cardiovascular disease in children, but which children need cardiac evaluation is unclear. We describe our experience evaluating 206 children for cardiac disease following SARS-CoV-2 infection (one of whom had ventricular ectopy) and propose a new guideline for management of these children. Routine cardiac screening after SARS-CoV-2 infection in children without any cardiac signs or symptoms does not appear to be high yield.
Copyright © 2021 Elsevier Inc. All rights reserved.
MeSH terms
-
Adolescent
-
Aftercare*
-
Ambulatory Care
-
Atrioventricular Block / diagnosis
-
Atrioventricular Block / etiology
-
Atrioventricular Block / physiopathology
-
Bradycardia / diagnosis
-
Bradycardia / etiology
-
Bradycardia / physiopathology
-
COVID-19 / complications
-
COVID-19 / physiopathology*
-
Cardiology
-
Chest Pain / physiopathology
-
Child
-
Child, Preschool
-
Dyspnea / physiopathology
-
Echocardiography
-
Electrocardiography
-
Fatigue / physiopathology
-
Female
-
Heart Diseases / diagnosis*
-
Heart Diseases / etiology
-
Heart Diseases / physiopathology
-
Humans
-
Hypertrophy, Left Ventricular / diagnosis
-
Hypertrophy, Left Ventricular / etiology
-
Hypertrophy, Left Ventricular / physiopathology
-
Hypertrophy, Right Ventricular / diagnosis
-
Hypertrophy, Right Ventricular / etiology
-
Hypertrophy, Right Ventricular / physiopathology
-
Implementation Science
-
Male
-
Pediatrics
-
Practice Guidelines as Topic
-
Referral and Consultation*
-
SARS-CoV-2
-
Severity of Illness Index
-
Syncope / physiopathology
-
Ventricular Premature Complexes / diagnosis
-
Ventricular Premature Complexes / etiology
-
Ventricular Premature Complexes / physiopathology
-
Young Adult